These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15306248

  • 21. Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism.
    Singh K, Singh S, Singhal NK, Sharma A, Parmar D, Singh MP.
    Chem Biol Interact; 2010 Apr 29; 185(2):81-93. PubMed ID: 20230807
    [Abstract] [Full Text] [Related]

  • 22. Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/Bax expression levels.
    Cao XQ, Arai H, Ren YR, Oizumi H, Zhang N, Seike S, Furuya T, Yasuda T, Mizuno Y, Mochizuki H.
    J Neurochem; 2006 Nov 29; 99(3):861-7. PubMed ID: 17076657
    [Abstract] [Full Text] [Related]

  • 23. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H, Kurosaki R, Oki C, Araki T.
    Brain Res; 2004 Dec 24; 1030(1):66-73. PubMed ID: 15567338
    [Abstract] [Full Text] [Related]

  • 24. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY, Park HJ, Ahn YH, Lee PH.
    J Neurochem; 2009 Nov 24; 111(4):1042-50. PubMed ID: 19765187
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
    Schneider JS, Kean A, DiStefano L.
    J Neurosci Res; 1995 Sep 01; 42(1):117-23. PubMed ID: 8531220
    [Abstract] [Full Text] [Related]

  • 27. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Yasuda Y, Shinagawa R, Yamada M, Mori T, Tateishi N, Fujita S.
    Brain Res; 2007 Mar 23; 1138():196-202. PubMed ID: 17275793
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
    Gibrat C, Saint-Pierre M, Bousquet M, Lévesque D, Rouillard C, Cicchetti F.
    J Neurochem; 2009 Jun 23; 109(5):1469-82. PubMed ID: 19457163
    [Abstract] [Full Text] [Related]

  • 30. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.
    Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351
    [Abstract] [Full Text] [Related]

  • 31. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK, Keyghobadi M, Moore C, Menashe RA, Meshul CK.
    Synapse; 2005 Aug 15; 57(2):100-12. PubMed ID: 15906381
    [Abstract] [Full Text] [Related]

  • 32. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W, Sripanichkulchai K, Finkelstein DI.
    Brain Res; 2006 Apr 21; 1084(1):28-37. PubMed ID: 16564034
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.
    Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW.
    J Neurosci Res; 2004 Aug 01; 77(3):378-90. PubMed ID: 15248294
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease.
    Depboylu C, Schorlemmer K, Klietz M, Oertel WH, Weihe E, Höglinger GU, Schäfer MK.
    J Neuroimmunol; 2011 Jul 01; 236(1-2):39-46. PubMed ID: 21640391
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.